Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients Stavros G. Drakos, MD,

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device

The STS National Database

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Long-Term Follow-Up of Cardiac Rhythm in 320 Patients After the Cox-Maze III Procedure for Atrial Fibrillation Anders Albåge, MD, PhD, Birgitta Johansson,

Niv Ad, MD, Linda Henry, PhD, Sharon Hunt, MBA, Sari D. Holmes, PhD

Investigating the Causes of Adverse Events

Poor Left Ventricular Performance in a Child With Coronary Sinus Stenosis: Successful Surgical Repair Sergey V. Gorbachevsky, MD, PhD, Anton A. Shmaltz,

Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.

Emergent Esophagectomy for Esophageal Perforations: A Safe Option

Complications and Risk Assessment of 25 Years in Pediatric Pacing

Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients Sheri Crow, MD, Dong Chen, MD, PhD, Carmelo Milano, MD, William.

Factors Influencing HLA Sensitization in Implantable LVAD Recipients

Clinical Impact of Mild Acute Kidney Injury After Cardiac Surgery

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Pleural Metastasis of Osteosarcoma

Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation Joshua C. Grimm, MD, Christopher.

Who Do You Say You Are? The Annals of Thoracic Surgery

Ventricular assist device programs: design and function

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

Use of Amiodarone After Major Lung Resection

Modified Ross Procedure to Prevent Autograft Dilatation

Progressive Tracheal Erosion Consecutive to a Calcified Left Thyroid Lobe Anne B. Olland, MD, MS, Pierre-Emmanuel Falcoz, MD, PhD, Nicola Santelmo, MD,

Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function Toshinobu.

Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Surgical management of valvular disease in patients requiring left ventricular assist device support Vivek Rao, MD, PhD, James P Slater, MD, Niloo M.

Electric Suction-Lavage Device for Video-Assisted Thoracoscopic Surgery Treatment of Empyema and Hemothorax Alon Ben-Nun, MD, PhD, Avi Waknin, RN, Michalle.

The Annals of Thoracic Surgery

Hybrid Management of a Giant Left Main Coronary Artery Aneurysm

Kenneth K. Liao, MD, Xiaohuan Li, MD, Ranjit John, MD, Devesh M

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Open, Video-Assisted Thoracic Surgery, and Robotic Lobectomy: Review of a National Database Michael Kent, MD, Thomas Wang, PhD, Richard Whyte, MD, Thomas.

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Editorial Board, January 2010

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

Rheumatoid Pleural Effusion in the Absence of Arthritic Disease

Vacuum-Assisted Closure for the Treatment of Complex Chest Wounds

Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD

Late Postpneumonectomy Death From Stump Thrombus

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Management of Empyema Cavity With the Vacuum-Assisted Closure Device

Off-Pump Plication of Left Ventricular Aneurysm

Patrick O. Myers, MD The Annals of Thoracic Surgery

Invited Commentary The Annals of Thoracic Surgery

Functional and Physiologic Results of Video-Assisted Thoracoscopic Diaphragm Plication in Adult Patients With Unilateral Diaphragm Paralysis Richard.

Robert Lee Replogle, September 30, 1931–May 9, 2016

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

James W. Long, MD, PhD, Aaron H. Healy, BS, Brad Y

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Multivariate Predictors of Heart Transplantation Outcomes in the Era of Chronic Mechanical Circulatory Support Stavros G. Drakos, MD, PhD, Abdallah G.

Posttraumatic Main Left Bronchial Rupture

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Use of Ventricular Assist Devices in Children Across the United States: Analysis of 7.5 Million Pediatric Hospitalizations David L.S. Morales, MD, Farhan.

Costs Associated With Ventricular Assist Device Use in Children

Late Consequences of a Much Earlier Decision

The Impact of New Technology on Cardiothoracic Surgical Practice

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: The impact of leukofiltered cellular blood product transfusions

Presentation transcript:

Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients Stavros G. Drakos, MD, Abdallah G. Kfoury, MD, James W. Long, MD, James C. Stringham, MD, Thomas C. Fuller, PhD, Karl E. Nelson, RN, Beverly K. Campbell, RN, Edward M. Gilbert, MD, Dale G. Renlund, MD The Annals of Thoracic Surgery Volume 82, Issue 3, Pages 889-893 (September 2006) DOI: 10.1016/j.athoracsur.2006.04.017 Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Incidence of sensitization. (Gray bars = intravenous immunoglobulin; black bars = no intravenous immunoglobulin; LVAD = left ventricular assist device; NS = not significant.) The Annals of Thoracic Surgery 2006 82, 889-893DOI: (10.1016/j.athoracsur.2006.04.017) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Panel reactive antibody (PRA). (Gray bars = intravenous immunoglobulin; black bars = no intravenous immunoglobulin; LVAD = left ventricular assist device; NS = not significant.) The Annals of Thoracic Surgery 2006 82, 889-893DOI: (10.1016/j.athoracsur.2006.04.017) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Overall sensitization rates during left ventricular assist device support. (Gray bars = intravenous immunoglobulin; black bars = no intravenous immunoglobulin; PRA = panel reactive antibody.) The Annals of Thoracic Surgery 2006 82, 889-893DOI: (10.1016/j.athoracsur.2006.04.017) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Peak panel reactive antibody (PRA). (Gray bar = intravenous immunoglobulin; black bar = no intravenous immunoglobulin.) The Annals of Thoracic Surgery 2006 82, 889-893DOI: (10.1016/j.athoracsur.2006.04.017) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions